Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.

An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...

Camila Alexandrina Figueiredo, Neuza Maria Alcântara-Neves, Rafael Veiga, Leila D. Amorim, Vitor Dattoli, Lívia Ribeiro Mendonça, Samuel Junqueira, Bernd Genser, Mariese Santos, Lain Carlos Pontes de ...

An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that ...

Despite the introduction of vaccines, the coronavirus disease 2019 (COVID-19) remains a significant problem around the world, particularly for people with weakened immune systems and those who have ...

(a, b) The stage 2 latency (S2L) and stage 5 latency (S5L) in the rosiglitazone-treated group were significantly greater than those in the sham and control groups. (c) Statistical analysis showing a ...

The function and regulation of the immune response triggered during malaria is complex and poorly understood, and there is a particular paucity of studies conducted in humans infected with Plasmodium ...

An immune signal promotes the production of energy-burning “beige fat,” according to a new study publishing August 5 th in the open-access journal PLOS Biology by Zhonghan Yang of Sun Yat-Sen ...

PITTSBURGH--(BUSINESS WIRE)--CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it has initiated ...